Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

107 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Dedicated multi-detector CT of the esophagus: spectrum of diseases.
Ba-Ssalamah A, Zacherl J, Noebauer-Huhmann IM, Uffmann M, Matzek WK, Pinker K, Herold C, Schima W. Ba-Ssalamah A, et al. Among authors: zacherl j. Abdom Imaging. 2009 Jan-Feb;34(1):3-18. doi: 10.1007/s00261-007-9290-5. Abdom Imaging. 2009. PMID: 17653787 Review.
Expression of Her-2 in carcinomas of the esophagus.
Schoppmann SF, Jesch B, Friedrich J, Wrba F, Schultheis A, Pluschnig U, Maresch J, Zacherl J, Hejna M, Birner P. Schoppmann SF, et al. Among authors: zacherl j. Am J Surg Pathol. 2010 Dec;34(12):1868-73. doi: 10.1097/PAS.0b013e3181f8be17. Am J Surg Pathol. 2010. PMID: 21107094
Docetaxel, cisplatin and 5-fluorouracil plus granulocyte colony-stimulating factor prophylaxis in patients with metastatic adenocarcinoma of the stomach and gastroesophageal junction: experience at the Medical University of Vienna.
Bojic M, Pluschnig U, Zacherl J, Thallinger CM, Ba-Ssalamah A, Maresch J, Datler P, Schoppmann SF, Hejna M. Bojic M, et al. Among authors: zacherl j. Anticancer Res. 2011 Jun;31(6):2379-82. Anticancer Res. 2011. PMID: 21737668
The biomarker TP53 divides patients with neoadjuvantly treated esophageal cancer into 2 subgroups with markedly different outcomes. A p53 Research Group study.
Kandioler D, Schoppmann SF, Zwrtek R, Kappel S, Wolf B, Mittlböck M, Kührer I, Hejna M, Pluschnig U, Ba-Ssalamah A, Wrba F, Zacherl J. Kandioler D, et al. Among authors: zacherl j. J Thorac Cardiovasc Surg. 2014 Nov;148(5):2280-6. doi: 10.1016/j.jtcvs.2014.06.079. Epub 2014 Jul 22. J Thorac Cardiovasc Surg. 2014. PMID: 25135238 Free article. Clinical Trial.
107 results